Xcout Intel
Sight Diagnostics
Sight Diagnostics pioneers a new generation of immune signatures by decoding live immune cells in action using proprietary data and artificial intelligence. The company provides cutting-edge clinical insights for healthcare and research applications.
Subscribe to see Sight Diagnostics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Sight Diagnostics at a glance
Sight Diagnostics is a healthtech, medical devices, ai/ml company headquartered in Israel. It has raised at least $98.8M across the 2 funding rounds on record. Its most recent funding round, Series D, raised $71M in July 2020. Xcout tracks 3 named people at Sight Diagnostics, including Nitsan Maayan-Rabinowich (Chief Executive Officer).
Sight Diagnostics leadership
- Nitsan Maayan-RabinowichChief Executive Officer
- Ben LeshemChief Technology Officer
- Asi Cohen-DotanChief Product & Clinical Officer
Sight Diagnostics funding rounds
At least $98.8M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $71M | 7 named | |
| Series C | $27.8M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Sight Diagnostics competitors
A few of Sight Diagnostics's closest competitors — see the full list of competitors and alternatives →
AEYE Health provides FDA-cleared, autonomous artificial intelligence solutions for diagnostic screening, specializing in instant diabetic retinopathy diagnosis using handheld and tabletop retinal cameras. The company serves primary care physicians, endocrinologists, and teleretinal screening providers by enabling on-the-spot diagnoses that eliminate the need for specialist referrals.
Imagene AI is a pioneering company in the field of AI-driven medical diagnostics, leveraging deep learning to analyze biological samples.
Entelai develops artificial intelligence solutions for clinical diagnosis, aimed at healthcare professionals, medical institutions, and patients. Its technology is designed to improve diagnostic accuracy, optimize medical workflows, and facilitate online medical prescriptions and studies.
Harrison.ai is an Australian healthcare technology company that develops clinically validated artificial-intelligence systems for medical imaging and other diagnostic applications. It works with healthcare providers and specialist clinical partners to support radiologists, pathologists, and other clinicians in diagnosis and workflow.
Pragmatech Ventures develops artificial intelligence, machine learning, and data engineering solutions for the healthcare and life sciences sectors, with a specialization in clinical microbiology and infectious diseases. The company provides Clinical Decision Support Systems (CDSS), predictive algorithms for diagnosis and treatment, natural language processing, data analytics, and optimization services to assist clinicians and healthcare systems.
Luminai provides an AI-powered healthcare automation platform designed for health systems. The company automates complex operational tasks such as referral intake, patient registration, claims management, and pharmacy renewals to streamline administrative workflows.
Get Sight Diagnostics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Sight Diagnostics in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access